Amgen Inc.
MX ˙ BMV ˙ NL0000888691
SecurityMX:AMGN / Amgen Inc.
InstitutionPittenger & Anderson Inc
Latest Disclosed Ownership3,033 shares
Latest Disclosed Value $ 1,067,162
Pittenger & Anderson Inc reports 2.02% increase in ownership of AMGN / Amgen Inc.

On May 1, 2026 - Pittenger & Anderson Inc filed a 13F-HR form disclosing ownership of 3,033 shares of Amgen Inc. (MX:AMGN) valued at $1,067,162 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 2, 2026 disclosing 2,973 shares of Amgen Inc.. This represents a change in shares of 2.02% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-01 2026-03-31 13F AMGEN COM 031162100 3,033 60 2.02 1,067 9.66 0.0425
2026-02-02 2025-12-31 13F AMGEN COM 031162100 2,973 90 3.12 973 19.68 0.0374
2025-11-03 2025-09-30 13F AMGEN COM 031162100 2,883 23 0.80 814 1.88 0.0298
2025-07-30 2025-06-30 13F AMGEN COM 031162100 2,860 400 16.26 799 4.18 0.0292
2025-05-01 2025-03-31 13F AMGEN COM 031162100 2,460 0 0.00 766 19.50 0.0281
2025-01-31 2024-12-31 13F AMGEN COM 031162100 2,460 0 0.00 641 -19.07 0.0233
2024-10-30 2024-09-30 13F AMGEN COM 031162100 2,460 0 0.00 793 3.13 0.0297
2024-08-09 2024-06-30 13F AMGEN COM 031162100 2,460 0 0.00 769 9.87 0.0316
2024-05-02 2024-03-31 13F AMGEN COM 031162100 2,460 0 0.00 699 -1.27 0.0284
2024-02-02 2023-12-31 13F AMGEN COM 031162100 2,460 0 0.00 709 7.11 0.0317
2023-11-02 2023-09-30 13F AMGEN COM 031162100 2,460 -300 -10.87 661 8.01 0.0333
2023-08-09 2023-06-30 13F AMGEN COM 031162100 2,760 0 0.00 613 -8.25 0.0295
2023-05-10 2023-03-31 13F AMGEN COM 031162100 2,760 0 0.00 667 -7.87 0.0345
2023-02-10 2022-12-31 13F AMGEN COM 031162100 2,760 0 0.00 725 16.40 0.0398
2022-11-15 2022-09-30 13F AMGEN COM 031162100 2,760 0 0.00 622 -7.44 0.0374
2022-07-14 2022-06-30 13F AMGEN COM 031162100 2,760 -14 -0.50 672 0.15 0.0392
2022-04-28 2022-03-31 13F AMGEN COM 031162100 2,774 -1,551 -35.86 671 -31.04 0.0329
2022-02-10 2021-12-31 13F AMGEN COM 031162100 4,325 -33,982 -88.71 973 -88.06 0.0449
2021-11-12 2021-09-30 13F AMGEN COM 031162100 38,307 -564 -1.45 8,146 -14.03 0.4087
2021-08-13 2021-06-30 13F AMGEN COM 031162100 38,871 281 0.73 9,475 -1.32 0.4853
2021-05-12 2021-03-31 13F AMGEN COM 031162100 38,590 2,652 7.38 9,602 16.20 0.5179
2021-02-11 2020-12-31 13F AMGEN COM 031162100 35,938 411 1.16 8,263 -8.49 0.4687
2020-11-10 2020-09-30 13F AMGEN COM 031162100 35,527 543 1.55 9,030 9.44 0.5766
2020-08-13 2020-06-30 13F AMGEN COM 031162100 34,984 367 1.06 8,251 17.57 0.5805
2020-04-30 2020-03-31 13F AMGEN COM 031162100 34,617 362 1.06 7,018 -15.02 0.5964
2020-02-12 2019-12-31 13F AMGEN COM 031162100 34,255 -117 -0.34 8,258 24.16 0.5523
2019-11-14 2019-09-30 13F AMGEN COM 031162100 34,372 -207 -0.60 6,651 4.38 0.4796
2019-08-09 2019-06-30 13F AMGEN COM 031162100 34,579 2,370 7.36 6,372 4.13 0.4768
2019-05-10 2019-03-31 13F AMGEN COM 031162100 32,209 657 2.08 6,119 -0.37 0.4786
2019-02-14 2018-12-31 13F AMGEN COM 031162100 31,552 612 1.98 6,142 -4.24 0.5640
2018-10-12 2018-09-30 13F AMGEN COM 031162100 30,940 900 3.00 6,414 15.67 0.5060
2018-08-15 2018-06-30 13F AMGEN COM 031162100 30,040 2,605 9.50 5,545 18.56 0.4742
2018-05-08 2018-03-31 13F AMGEN COM 031162100 27,435 4,052 17.33 4,677 15.03 0.4096
2018-02-13 2017-12-31 13F AMGEN COM 031162100 23,383 125 0.54 4,066 -6.23 0.3558
2017-11-13 2017-09-30 13F AMGEN COM 031162100 23,258 -235 -1.00 4,336 7.17 0.3933
2017-08-10 2017-06-30 13F AMGEN COM 031162100 23,493 -1,912 -7.53 4,046 -2.93 0.3866
2017-05-15 2017-03-31 13F AMGEN COM 031162100 25,405 500 2.01 4,168 14.47 0.4189
2017-02-16 2016-12-31 13F AMGEN COM 031162100 24,905 -835 -3.24 3,641 -15.21 0.3872
2016-11-14 2016-09-30 13F AMGEN COM 031162100 25,740 3,510 15.79 4,294 26.97 0.4765
2016-08-09 2016-06-30 13F AMGEN COM 031162100 22,230 6,255 39.15 3,382 41.21 0.3730
2016-05-13 2016-03-31 13F AMGEN COM 031162100 15,975 440 2.83 2,395 -5.04 0.2785
2016-02-10 2015-12-31 13F AMGEN COM 031162100 15,535 5,460 54.19 2,522 80.92 0.3159
2015-11-10 2015-09-30 13F AMGEN COM 031162100 10,075 1,325 15.14 1,394 3.80 0.1842
2015-08-14 2015-06-30 13F AMGEN COM 031162100 8,750 1,450 19.86 1,343 15.08 0.1724
2015-05-12 2015-03-31 13F AMGEN COM 031162100 7,300 7,300 1,167 0.1503
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.